Citation

Ann J Melvin, Ka Lai Yee, Kathryn P Gray, Mounika Yedla, Hong Wan, Nicole H. Tobin, Hedy Teppler, Havilland Campbell, Katie McCarthy, Rachel Scheckter, Linda Aurpibul, Pradthana Ounchanum, Supattra Rungmaitree, Hassena Cassim, Elizabeth McFarland, Patricia Flynn, Ellen Cooper, Chelsea Krotje, Ellen Townley, Jack Moye, Brookie M. Best, IMPAACT 2014 Study Team. Pharmacokinetics, tolerability, and safety of doravirine and doravirine/lamivudine/tenofovir disoproxil fumarate fixed dose combination tablets in adolescents living with HIV: Week 24 results from IMPAACT 2014. Journal of AIDS. 2023. PMID: 36215957

Citation

Benjamin H. Chi, Dorothy Sebikari, Sean S. Brummel, Patricia DeMarrais, Rachel Chamanga, Maxensia Owor, Sufia Dadabhai, Joan T. Price, Taha Taha, Jeffrey Stringer, Mary Glenn Fowler. Progesterone and prolactin levels in pregnant women living with HIV who delivered preterm and low birthweight infants: A nested case-control study. PLoS One. 2023. 18: e0280730. PMID: 36689442

Citation

Patricia Mandima, Kristin Baltrusaitis, Grace Montepiedra, Lisa Aaron, Jyoti Mathad, Carolyne Onyango-Makumbi, Mandisa Nyati, James Ngocho, Gift Chareka, Ponego Ponatshego, Gaerolwe Masheto, Katie McCarthy, Patrick Jean-Philippe, Amita Gupta, Lynda Stranix-Chibanda, IMPAACT P1078 TB APPRISE study team. Prevalence of neurotoxicity symptoms among postpartum women on Isoniazid Preventive Therapy and Efavirenz-based treatment for HIV: An exploratory objective of the IMPAACT P1078 randomized trial. Journal of Acquired Immune Deficiency Syndromes. 2023. PMID: 36650479

Citation

Coleen K. Cunningham, Ruth A. Karron, Petronella Muresan, Matthew S. Kelly, Elizabeth J. McFarland, Charlotte Perlowski, Jennifer Libous, Jennifer Oliva, Patrick Jean-Philippe, Jack Moye Jr., Elizabeth Schappell, Emily Barr, Vivian Rexroad, Benjamin Johnston, Ellen G. Chadwick, Mikhaela Cielo, Mary Paul, Jaime G. Deville, Mariam Aziz, Lijuan Yang, Cindy Luongo, Peter L. Collins, Ursula J. Buchholz, IMPAACT 2018 Study Team. Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/delta NS2/delta 1313/I1314L and RSV/276 in RSV-Seronegative Children. Journal of Infectious Diseases. 2022. 226: 2069-2078. PMID: 35732186

Citation

Conrado Milani Coutinho, Meredith G. Warshaw, Geraldo Duarte, Alice Stek, Avy Violari, Cristina B. Hofer, Jaime G. Deville, James Samwel Ngocho, José Henrique Pilotto, Mario Dias Correa Jr., David E. Shapiro, Trevon L. Fuller, Nahida Chakhtoura, Mark Mirochnick, Esaú C. João. Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081. Journal of Acquired Immune Deficiency Syndromes. 2022. 91: 403-409. PMID: 36049477

Citation

Teacler G. Nematadzira, Pamela M. Murnane, Osamuedeme J. Odiase, Peter Bacchetti, Hideaki Okochi, Regina Tallerico, Vongai M. Chanaiwa, Tichaona Vhembo, Mercy T. Mutambanengwe-Jacob, Alexander Louie, Tsungai Chipato, Monica Gandhi, Lynda Stranix-Chibanda, IMPAACT PROMISE Study Team. Antiretroviral Therapy Adherence During and Postbreastfeeding Cessation Measured by Tenofovir Levels in Hair. Journal of Acquired Immune Deficiency Syndromes. 2022. 91: 237-241. PMID: 35952357

Citation

Larry K. Brown, Kristin Baltrusaitis, Betsy D. Kennard, Graham J. Emslie, Miriam Chernoff, Sarah Buisson, Kathryn Lypen, Laura B. Whiteley, Shirley Traite, Chelsea Krotje, Kevin Knowles, Ellen Townley, Jaime Deville, Megan Wilkins, Dan Reirden, Mary Paul, Christy Beneri, David E. Shapiro, IMPAACT 2002 team. Forty-eight Week Outcomes of a Site-Randomized Trial of Combined Cognitive Behavioral Therapy and Medication Management Algorithm for Treatment of Depression Among Youth Living with HIV in the United States. Journal of Acquired Immune Deficiency Syndromes. 2022. 91: 296-304. PMID: 35839439

Citation

V Rouzier, M Murrill, S Kim, L Naini, J Shenje, E Mitchell, M Raesi, M Lourens, A Mendoza, F Conradie, N Suryavanshi, M Hughes, S Shah, G Churchyard, S Swindells, A Hesseling, A Gupta. Caregiver willingness to give TPT to children living with drug-resistant TB patients. International Journal of Tuberculosis and Lung Disease. 2022. 26: 949-955. PMID: 36163664

Citation

Agathe Béranger, Adrie Bekker, Belén P. Solans, Mark F. Cotton, Mark Mirochnick, Avy Violari, Jiajia Wang, Mae Cababasay, Lubbe Wiesner, Renee Browning, Jack Moye, Edmund V. Capparelli, Radojka M. Savic. Influence of NAT2 genotype and maturation on isoniazid exposure in low-birth-weight and preterm infants with or without HIV exposure. Clinical Infectious Diseases. 2022. PMID: 35134861

Citation

Ceejay L. Boyce, Ingrid A. Beck, Sheila M. Styrchak, Samantha R. Hardy, Jackson J. Wallner, Ross S. Milne, R. Leavitt Morrison, David Shapiro, Esaú C João, Mark Mirochnick, Lisa M. Frenkel. Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term. PLoS One. 2022. 17: e0275254. PMID: 36166463